Ocugen (OCGN) News Today $0.81 +0.04 (+5.22%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OCGN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Noble Financial Predicts Ocugen's Q2 Earnings (NASDAQ:OCGN)Ocugen, Inc. (NASDAQ:OCGN - Free Report) - Stock analysts at Noble Financial upped their Q2 2025 earnings estimates for shares of Ocugen in a research note issued to investors on Monday, May 12th. Noble Financial analyst R. Leboyer now expects that the company will post earnings per share of ($0.May 16, 2025 | marketbeat.comNoble Financial Issues Positive Forecast for Ocugen EarningsMay 16, 2025 | americanbankingnews.comThe Analyst Verdict: Ocugen In The Eyes Of 5 ExpertsMay 14, 2025 | nasdaq.comOcugen (NASDAQ:OCGN) Price Target Cut to $7.00 by Analysts at HC WainwrightHC Wainwright reduced their target price on shares of Ocugen from $8.00 to $7.00 and set a "buy" rating for the company in a report on Monday.May 14, 2025 | marketbeat.comOcugen's (OCGN) "Buy" Rating Reiterated at Chardan CapitalChardan Capital restated a "buy" rating and set a $7.00 price objective on shares of Ocugen in a research report on Monday.May 14, 2025 | marketbeat.comHC Wainwright Has Lowered Expectations for Ocugen (NASDAQ:OCGN) Stock PriceMay 14, 2025 | americanbankingnews.comOcugen (NASDAQ:OCGN) Releases Earnings Results, Beats Estimates By $0.01 EPSOcugen (NASDAQ:OCGN - Get Free Report) issued its earnings results on Friday. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.06) by $0.01. The business had revenue of $1.48 million during the quarter. Ocugen had a negative return on equity of 154.75% and a negative net margin of 532.51%.May 13, 2025 | marketbeat.comOcugen Reports Progress in Q1 2025 with Advancements in Gene TherapyMay 13, 2025 | msn.com1OCGN : The Analyst Verdict: Ocugen In The Eyes Of 5 ExpertsMay 13, 2025 | benzinga.comOcugen, Inc. (NASDAQ:OCGN) Q1 2025 Earnings Call TranscriptMay 10, 2025 | msn.comOcugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns BullishMay 9, 2025 | msn.comOcugen, Inc. (OCGN) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comOcugen Provides Business Update with First Quarter 2025 Financial ResultsMay 9, 2025 | globenewswire.comA Look at Ocugen's Upcoming Earnings ReportMay 9, 2025 | benzinga.comOcugen (OCGN) Projected to Post Earnings on FridayOcugen (NASDAQ:OCGN) will be releasing its Q1 2025 earnings before the market opens on Friday, May 9. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-9-ocugen-inc-stock/)May 6, 2025 | marketbeat.comOcugen to Host Q1 2025 Earnings Call and Business Update on May 9May 5, 2025 | msn.comOCUGEN Earnings Preview: Recent $OCGN Insider Trading, Hedge Fund Activity, and MoreMay 2, 2025 | nasdaq.comOcugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial ResultsMay 2, 2025 | globenewswire.comOcugen to Showcase Gene Therapy Advances at Upcoming Ophthalmology ConferencesMay 2, 2025 | msn.comOcugen to Showcase Gene Therapy Advances at Upcoming Ophthalmology ConferencesMay 2, 2025 | msn.comOcugen to Present at Eyecelerator Conference May 2025May 1, 2025 | tipranks.comOcugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2025 Annual Meeting and Retina World CongressApril 29, 2025 | globenewswire.comRenaissance Technologies LLC Invests $1.68 Million in Ocugen, Inc. (NASDAQ:OCGN)Renaissance Technologies LLC acquired a new position in Ocugen, Inc. (NASDAQ:OCGN - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 2,087,632 shares of the company's stock, valued at approximately $1,681,000.April 29, 2025 | marketbeat.comOcugen Inc. stock rises Tuesday, still underperforms marketApril 23, 2025 | marketwatch.comIs Ocugen Inc. (NASDAQ:OCGN) the Best Penny Stock to Invest in Under $1?April 17, 2025 | msn.comOcugen CEO to Present at Prestigious Cell & Gene Meeting on the MediterraneanApril 10, 2025 | msn.comOcugen management to meet with MaximApril 9, 2025 | markets.businessinsider.comOcugen to Present at the 2025 Cell & Gene Meeting on the MedApril 8, 2025 | globenewswire.comStargardt Disease Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Acucela, Astellas Pharma, Alkeus PharmaApril 7, 2025 | theglobeandmail.comChardan Capital Forecasts Ocugen FY2025 EarningsOcugen, Inc. (NASDAQ:OCGN - Free Report) - Equities research analysts at Chardan Capital issued their FY2025 EPS estimates for shares of Ocugen in a note issued to investors on Monday, March 24th. Chardan Capital analyst D. Gataulin forecasts that the company will earn ($0.25) per share for the yMarch 28, 2025 | marketbeat.comOcugen Advances OCU200 Clinical Trial Amid Promising Safety ResultsMarch 19, 2025 | msn.comOcugen says DSMB approves dosing Cohort 2 in OCU200 clinical trialMarch 18, 2025 | markets.businessinsider.comData and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200—a Novel Fusion Protein for Diabetic Macular EdemaMarch 18, 2025 | globenewswire.comHC Wainwright Forecasts Ocugen's Q1 Earnings (NASDAQ:OCGN)Ocugen, Inc. (NASDAQ:OCGN - Free Report) - Stock analysts at HC Wainwright reduced their Q1 2025 earnings estimates for shares of Ocugen in a research note issued on Thursday, March 6th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($0.05) per share for the quarter, dMarch 11, 2025 | marketbeat.comEquities Analysts Offer Predictions for Ocugen Q1 EarningsOcugen, Inc. (NASDAQ:OCGN - Free Report) - Investment analysts at HC Wainwright cut their Q1 2025 EPS estimates for Ocugen in a research report issued on Thursday, March 6th. HC Wainwright analyst S. Ramakanth now forecasts that the company will post earnings of ($0.05) per share for the quarter,March 10, 2025 | marketbeat.comWhat is HC Wainwright's Estimate for Ocugen FY2029 Earnings?Ocugen, Inc. (NASDAQ:OCGN - Free Report) - Stock analysts at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for shares of Ocugen in a research note issued to investors on Thursday, March 6th. HC Wainwright analyst S. Ramakanth forecasts that the company will post earnings peMarch 8, 2025 | marketbeat.comChardan Capital Issues Positive Forecast for Ocugen (NASDAQ:OCGN) Stock PriceChardan Capital lifted their price target on Ocugen from $6.00 to $7.00 and gave the stock a "buy" rating in a report on Thursday.March 7, 2025 | marketbeat.comOcugen (NASDAQ:OCGN) Receives "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $8.00 price objective on shares of Ocugen in a research report on Thursday.March 7, 2025 | marketbeat.comOcugen (NASDAQ:OCGN) Announces Quarterly Earnings Results, Hits EstimatesOcugen (NASDAQ:OCGN - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($0.05) earnings per share for the quarter, hitting the consensus estimate of ($0.05). Ocugen had a negative net margin of 532.51% and a negative return on equity of 154.75%. During the same period in the previous year, the firm earned ($0.03) EPS.March 6, 2025 | marketbeat.comOcugen, Inc. (NASDAQ:OCGN) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | msn.comAttention Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); MGP Ingredients, Inc. (NASDAQ: MGPI); and Ocugen, Inc. (NASDAQ: OCGN): Grabar Law Office Investigates Claims on Your BehalfMarch 6, 2025 | financialpost.comOcugen, Inc. (OCGN) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | seekingalpha.comOcugen reports Q4 EPS (5c), consensus (5c)March 6, 2025 | markets.businessinsider.comOcugen (OCGN) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | msn.comOcugen Reports Progress in Gene Therapy TrialsMarch 5, 2025 | tipranks.comOcugen Provides Business Update with Fourth Quarter and Full Year 2024 Financial ResultsMarch 5, 2025 | globenewswire.comNoble Financial Sticks to Its Buy Rating for Ocugen (OCGN)March 4, 2025 | markets.businessinsider.comOcugen announces EC provided position opinion from EMA’s CAT for OCU410March 3, 2025 | markets.businessinsider.comGrabar Law Office is Investigating Claims on Behalf of Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Ocugen, Inc. (NASDAQ: OCGN)March 3, 2025 | financialpost.comAnalysts Offer Insights on Healthcare Companies: Ventyx Biosciences (VTYX) and Ocugen (OCGN)March 1, 2025 | markets.businessinsider.com Get Ocugen News Delivered to You Automatically Sign up to receive the latest news and ratings for OCGN and its competitors with MarketBeat's FREE daily newsletter. Email Address OCGN Media Mentions By Week OCGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCGN News Sentiment▼0.710.65▲Average Medical News Sentiment OCGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCGN Articles This Week▼114▲OCGN Articles Average Week Get Ocugen News Delivered to You Automatically Sign up to receive the latest news and ratings for OCGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CureVac News Pharvaris News CorMedix News Bicara Therapeutics News Enliven Therapeutics News Zymeworks News LENZ Therapeutics News Chimerix News Avid Bioservices News Cronos Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OCGN) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocugen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocugen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
